Solstice, which uses clinical and compliance documents and AI to accelerate advertising approvals for pharma clients, raised a $21M Series A (Brock E.W. Turner/Axios)

Techmeme ·

Solstice raised $21 million to expand AI-assisted pharma advertising approval workflows using clinical and compliance documents.

Categories: Money & Moves

Excerpt

<a href="https://www.axios.com/pro/health-tech-deals/2026/05/27/transformation-capital-solstice-21m-pharma-marketing"><img align="RIGHT" border="0" hspace="4" src="http://www.techmeme.com/260531/i16.jpg" vspace="4" /></a> <p><a href="https://www.techmeme.com/260531/p16#a260531p16" title="Techmeme permalink"><img height="12" src="http://www.techmeme.com/img/pml.png" style="border: none; padding: 0; margin: 0;" width="11" /></a> Brock E.W. Turner / <a href="https://www.axios.com/">Axios</a>:<br /> <span style="font-size: 1.3em;"><b><a href="https://www.axios.com/pro/health-tech-deals/2026/05/27/transformation-capital-solstice-21m-pharma-marketing">Solstice, which uses clinical and compliance documents and AI to accelerate advertising approvals for pharma clients, raised a $21M Series A</a></b></span>&nbsp; &mdash;&nbsp; Pharma marketing company Solstice raised $21 million in Series A funding led by Transformation Capital, CEO Aris Saxena tells Axios Pro exclusively.</p>